PAVmed Inc

Insider buying surge at PAVmed: CEO’s 350k‑share grant, 1.4m shares bought by execs, signals confidence ahead of new PortIO device and Octeris imaging launch.

Insider buying at PAVmed shows executives betting on new products and strategic hires, signaling confidence in a potential rebound despite recent volatility.

Discover how PAVmed’s insider grants and new PortIO device promise a turnaround, aligning exec incentives with long‑term growth and potential upside.